237 related articles for article (PubMed ID: 31104064)
1. Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.
Huang H; Qiu Y; Huang G; Zhou X; Zhou X; Luo W
Med Sci Monit; 2019 May; 25():3700-3715. PubMed ID: 31104064
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors.
Hu ZW; Chen L; Ma RQ; Wei FQ; Wen YH; Zeng XL; Sun W; Wen WP
Aging (Albany NY); 2021 Apr; 13(8):11491-11506. PubMed ID: 33864445
[TBL] [Abstract][Full Text] [Related]
3. [Expression of FTL and FTH genes encoding ferretin subunits in lung and renal carcinomas].
Kudriavtseva AV; Anedchenko EA; Oparina NIu; Krasnov GS; Kashkin KN; Dmitriev AA; Zborobskaia IB; Kondtrat'eva TT; Vinogradova TV; Zinov'eva MV; Kopantsev EP; Senchenko VN
Mol Biol (Mosk); 2009; 43(6):1044-54. PubMed ID: 20088381
[TBL] [Abstract][Full Text] [Related]
4. Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.
Liu NQ; De Marchi T; Timmermans AM; Beekhof R; Trapman-Jansen AM; Foekens R; Look MP; van Deurzen CH; Span PN; Sweep FC; Brask JB; Timmermans-Wielenga V; Debets R; Martens JW; Foekens JA; Umar A
Mol Cell Proteomics; 2014 Jul; 13(7):1814-27. PubMed ID: 24742827
[TBL] [Abstract][Full Text] [Related]
5. FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma.
Liao Q; Yang J; Lu Z; Jiang Q; Gong Y; Liu L; Peng H; Wang Q; Zhang X; Liu Z
PeerJ; 2023; 11():e16493. PubMed ID: 38025726
[TBL] [Abstract][Full Text] [Related]
6. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
Xue Y; Wu G; Liao Y; Xiao G; Ma X; Zou X; Zhang G; Xiao R; Wang X; Liu Q; Long D; Yang J; Xu H; Liu F; Liu M; Xie K; Huang R
Br J Cancer; 2014 Apr; 110(9):2250-60. PubMed ID: 24595000
[TBL] [Abstract][Full Text] [Related]
7. Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia.
Bertoli S; Paubelle E; Bérard E; Saland E; Thomas X; Tavitian S; Larcher MV; Vergez F; Delabesse E; Sarry A; Huguet F; Larrue C; Bosc C; Farge T; Sarry JE; Michallet M; Récher C
Eur J Haematol; 2019 Feb; 102(2):131-142. PubMed ID: 30325535
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ
Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173
[TBL] [Abstract][Full Text] [Related]
9. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
10. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
Zeng Q; Zhang W; Li X; Lai J; Li Z
Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
13. Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?
Masuda A; Kamai T; Abe H; Arai K; Yoshida K
Biomed Res; 2009 Jun; 30(3):171-6. PubMed ID: 19574718
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
[TBL] [Abstract][Full Text] [Related]
15. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G
J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713
[TBL] [Abstract][Full Text] [Related]
16. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
17. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma.
Liu G; Lu Y; Li L; Jiang T; Chu S; Hou P; Bai J; Chen M
Invest New Drugs; 2020 Dec; 38(6):1730-1742. PubMed ID: 32533288
[TBL] [Abstract][Full Text] [Related]
18. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
19. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
